HK1125831A1 - Fat accumulation inhibitor for the treatment of metabolic syndrome - Google Patents

Fat accumulation inhibitor for the treatment of metabolic syndrome

Info

Publication number
HK1125831A1
HK1125831A1 HK09103705.1A HK09103705A HK1125831A1 HK 1125831 A1 HK1125831 A1 HK 1125831A1 HK 09103705 A HK09103705 A HK 09103705A HK 1125831 A1 HK1125831 A1 HK 1125831A1
Authority
HK
Hong Kong
Prior art keywords
treatment
metabolic syndrome
fat accumulation
accumulation inhibitor
inhibitor
Prior art date
Application number
HK09103705.1A
Other languages
English (en)
Inventor
Reo Tanaka
Tomoyuki Isogai
Yuko Haruta
Susumu Miura
Ken Kato
Toshimitsu Yoshioka
Hiroshi Kawakami
Satoshi Higurashi
Hiroaki Matsuyama
Original Assignee
Megmilk Snow Brand Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38581260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1125831(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP2006106164A external-priority patent/JP5077982B2/ja
Priority claimed from JP2006152507A external-priority patent/JP2007320900A/ja
Application filed by Megmilk Snow Brand Co Ltd filed Critical Megmilk Snow Brand Co Ltd
Publication of HK1125831A1 publication Critical patent/HK1125831A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK09103705.1A 2006-04-07 2009-04-22 Fat accumulation inhibitor for the treatment of metabolic syndrome HK1125831A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006106164A JP5077982B2 (ja) 2006-04-07 2006-04-07 脂肪蓄積抑制剤
JP2006152507A JP2007320900A (ja) 2006-05-31 2006-05-31 内臓脂肪蓄積抑制剤及び、血中アディポネクチン濃度増加促進及び／又は減少抑制剤
PCT/JP2007/057791 WO2007116981A1 (ja) 2006-04-07 2007-04-06 脂肪蓄積抑制剤

Publications (1)

Publication Number Publication Date
HK1125831A1 true HK1125831A1 (en) 2009-08-21

Family

ID=38581260

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09103705.1A HK1125831A1 (en) 2006-04-07 2009-04-22 Fat accumulation inhibitor for the treatment of metabolic syndrome

Country Status (9)

Country Link
US (2) US20090253658A1 (xx)
EP (1) EP2011500B1 (xx)
KR (1) KR20080108523A (xx)
AU (1) AU2007236638B2 (xx)
CA (1) CA2648653C (xx)
ES (1) ES2431142T3 (xx)
HK (1) HK1125831A1 (xx)
NZ (2) NZ601174A (xx)
WO (1) WO2007116981A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5208428B2 (ja) * 2007-01-30 2013-06-12 雪印メグミルク株式会社 美肌剤
CN101939010A (zh) * 2007-11-19 2011-01-05 雪印乳业株式会社 感觉改善剂
JP5311804B2 (ja) * 2007-11-19 2013-10-09 雪印メグミルク株式会社 感覚改善剤
JP2009126787A (ja) * 2007-11-19 2009-06-11 Snow Brand Milk Prod Co Ltd 感覚改善剤
CN101909610B (zh) * 2007-12-28 2013-12-04 尤尼蒂卡株式会社 口服给药组合物
JP5465834B2 (ja) 2008-01-15 2014-04-09 雪印メグミルク株式会社 肝機能保護剤
PL2262514T3 (pl) 2008-03-07 2020-06-15 Savencia Sa Środki do wspomagania wydzielania i/lub hamowania spadku adiponektyny
JP2011084485A (ja) * 2009-10-13 2011-04-28 Snow Brand Milk Prod Co Ltd 脂肪蓄積抑制剤
JP5581071B2 (ja) * 2010-02-03 2014-08-27 花王株式会社 ミトコンドリア機能向上剤
EP2532351B1 (en) * 2010-02-03 2015-07-08 Kao Corporation Agent for improving motility function
KR20170025909A (ko) 2015-08-31 2017-03-08 가천대학교 산학협력단 스핑고신 1-인산 또는 Sphk2의 발현을 상승시키는 물질을 포함하는 대사 기능 장애의 예방 또는 치료용 약학 조성물
US11425915B2 (en) 2018-05-02 2022-08-30 Land O'lakes, Inc. Methods of concentrating phospholipids

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321287A3 (en) * 1987-12-18 1990-11-22 City of Hope Inhibition of lipogenesis
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
JP2805522B2 (ja) 1989-04-25 1998-09-30 雪印乳業株式会社 乳または乳製品由来のリン脂質画分を分画精製する方法
JP3103218B2 (ja) * 1991-10-09 2000-10-30 雪印乳業株式会社 乳由来の複合脂質を高含有する粉末、その製造方法及び用途
JP3131282B2 (ja) 1991-11-12 2001-01-31 ポーラ化成工業株式会社 消炎鎮痛外用剤
SE501697C2 (sv) * 1993-02-11 1995-04-24 Svenska Mejeriernas Riksforeni Förfarande för utvinning av sfingomyelin
JPH07173182A (ja) * 1993-12-17 1995-07-11 Meiji Milk Prod Co Ltd リン脂質を主成分とする乳由来の極性脂質の抽出方法及び濃縮方法
US20020182250A1 (en) * 1995-09-06 2002-12-05 Goro Hori Lipid metabolism improving agent
JPH1084880A (ja) 1996-09-13 1998-04-07 Takeda Shokuhin Kogyo Kk 脂質代謝促進作用を有するリン脂質含有組成物
JP3581010B2 (ja) 1998-03-18 2004-10-27 雪印乳業株式会社 脂質の消化吸収機能改善剤
US6897019B1 (en) * 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
JP3958885B2 (ja) * 1999-01-27 2007-08-15 長谷川香料株式会社 保存安定性に優れた粉末素材
JP3891536B2 (ja) * 2000-03-30 2007-03-14 明治乳業株式会社 哺乳動物の乳由来のリン脂質含有経口性組成物
WO2002034062A1 (en) * 2000-10-27 2002-05-02 Nv Marc Boone Method for obtaining products enriched in phospho- and sphingolipids
JP4995377B2 (ja) * 2001-04-26 2012-08-08 花王株式会社 油脂組成物
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
JP2003252765A (ja) 2002-02-28 2003-09-10 Snow Brand Milk Prod Co Ltd 腸管運動機能不全性疾患の治療剤
JP4011938B2 (ja) 2002-03-08 2007-11-21 株式会社ヤクルト本社 脂質代謝改善剤及びそれを含有する食品
JP2004099539A (ja) 2002-09-10 2004-04-02 Wakamoto Pharmaceut Co Ltd 内臓脂肪蓄積防止組成物又は食品
ATE427106T1 (de) * 2003-01-20 2009-04-15 Tno Die verwendung von sphingolipiden zur senkung der cholesterin- und triglyzeridspiegel im plasma.
NL1022442C2 (nl) * 2003-01-20 2004-07-22 Tno Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen.
WO2006006286A1 (ja) * 2004-07-09 2006-01-19 Meiji Dairies Corporation Pparおよび／またはppar関連因子産生増強組成物
US7666447B2 (en) * 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
EP2308324A1 (en) * 2005-05-31 2011-04-13 Arla Foods amba Phosphatidylserine enriched milk fractions for the formulation of functional foods

Also Published As

Publication number Publication date
NZ601174A (en) 2013-10-25
AU2007236638B2 (en) 2013-09-26
KR20080108523A (ko) 2008-12-15
EP2011500A4 (en) 2012-01-04
CA2648653A1 (en) 2007-10-18
US20090253658A1 (en) 2009-10-08
WO2007116981A1 (ja) 2007-10-18
EP2011500B1 (en) 2013-09-11
AU2007236638A1 (en) 2007-10-18
US20120077780A1 (en) 2012-03-29
NZ571807A (en) 2013-05-31
EP2011500A1 (en) 2009-01-07
CA2648653C (en) 2014-05-13
ES2431142T3 (es) 2013-11-25

Similar Documents

Publication Publication Date Title
HK1125831A1 (en) Fat accumulation inhibitor for the treatment of metabolic syndrome
EP1976377A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
EP1983972A4 (en) COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
ZA200806074B (en) Compounds for the treatment of inflammatory disorders
IL195203A0 (en) Compounds for the treatment of metabolic disorders
IL186749A0 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
IL197001A0 (en) Combination treatment for metabolic disorders
IL193484A0 (en) Gsk-3 inhibitors for the treatment of osteoporosis
PL1940839T3 (pl) Pirydopirymidynonowe inhibitory PI3Kalfa
EP1981526A4 (en) ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS
EP2049505A4 (en) ISOFORM SELECTIVE HDAC HEMMER
IL194189A0 (en) Combination treatment of metabolic disorders
ZA200805645B (en) Compounds for the treatment of metabolic disorders
EP1982724A4 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF METABOLIC SYNDROME AND FOODS CONTAINING THE SAME
EP2020231A4 (en) FAT ABSORPTION INHIBITORS
EP2056830A4 (en) SPECIAL COMPOSITIONS FOR TREATMENT OR PREVENTION OF METABOLIC SYNDROME
IL192851A0 (en) Compounds for the treatment of metabolic disorders
IL182055A0 (en) Agent for prophylaxis or treatment of metabolic syndrome
IL195392A0 (en) Compounds for the treatment of metabolic disorders
EP2023894A4 (en) FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE
GB0604781D0 (en) Use of substituted phenyl-piperazine compounds for the treatment of food related disorders
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
IL192982A0 (en) Compounds for the treatment of metabolic disorders
GB0602857D0 (en) The treatment of sialorrhoea
GB0609792D0 (en) The treatment of multiple sclerosis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180406